Ocumox Ophthalmic Solution 0.5% is a broad-spectrum antibiotic belonging to the fluoroquinolone class. It is used to treat various bacterial infections by inhibiting bacterial DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication and repair.
Moxifloxacin is used to treat a range of bacterial infections, including:
| Brand Name | Ocumox |
|---|---|
| Type | Ophthalmic Solution |
| Weight | 0.5% |
| Generic | Moxifloxacin Hydrochloride |
| Manufacturer | Reman Drug Laboratories Ltd. |
| Available in | English বাংলা |
Moxifloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV. These enzymes are crucial for bacterial DNA replication, transcription, and repair. By blocking these enzymes, Moxifloxacin prevents bacterial cell division and growth, leading to bacterial death.
The onset of action for Moxifloxacin is generally within 1-2 hours after administration. Improvement in symptoms is often observed within 48 hours of starting treatment. Full therapeutic effects can take several days to become apparent, depending on the infection's severity and the patient’s overall health.
Moxifloxacin is well absorbed after oral administration, with a bioavailability of approximately 90%. It is rapidly absorbed from the gastrointestinal tract, and peak plasma concentrations are typically reached within 1-4 hours.
Moxifloxacin is primarily eliminated through the liver. It undergoes extensive hepatic metabolism, and its metabolites are excreted in the bile. A small amount is excreted unchanged in the urine.
The usual dosage for Moxifloxacin is:
Moxifloxacin can be administered orally in the form of tablets or intravenously. It should be taken with a full glass of water and can be taken with or without food. The oral tablets should not be crushed or chewed.
Common side effects of Moxifloxacin include:
Serious side effects can include:
In cases of overdose, symptoms may include nausea, vomiting, and dizziness. Severe cases may present with more serious effects such as seizures or cardiac disturbances. Immediate medical attention is required in cases of overdose to manage symptoms and provide supportive care.
Precautions include:
Moxifloxacin may interact with other medications, including:
Use with caution in patients with:
Drugs that may interact with Moxifloxacin include:
Food does not significantly affect the absorption of Moxifloxacin. However, it is recommended to avoid taking it with dairy products or high-calcium foods as they can interfere with absorption.
Moxifloxacin should be used during pregnancy only if the potential benefits outweigh the risks. It is classified as a Category C drug, meaning there are no adequate studies in pregnant women, and it should be used with caution.
Moxifloxacin is excreted in breast milk, and its use during lactation is generally not recommended unless necessary. If use is required, it is advisable to monitor the infant for any adverse effects.
In the event of an acute overdose, seek immediate medical attention. Treatment may involve supportive measures and symptomatic management. Activated charcoal may be administered if the overdose is recent and appropriate.
Moxifloxacin is contraindicated in individuals with a known hypersensitivity to Moxifloxacin or other fluoroquinolones. It is also contraindicated in patients with a history of tendon disorders related to fluoroquinolone use.
Follow the prescribed dosage and administration guidelines. Do not exceed the recommended dose or duration of treatment without consulting a healthcare provider. Complete the full course of therapy even if symptoms improve.
Store Moxifloxacin tablets at room temperature, away from light and moisture. Keep them in their original container, tightly closed, and out of reach of children.
The volume of distribution for Moxifloxacin is approximately 2-3 L/kg, indicating that it is widely distributed throughout the body tissues and fluids.
The elimination half-life of Moxifloxacin is approximately 12-15 hours, which supports once-daily dosing for most infections.
Moxifloxacin is primarily cleared through hepatic metabolism, with its clearance being reduced in patients with liver impairment. A small fraction is excreted unchanged in the urine.
See in details version Ocumox Ophthalmic Solution 0.5% also Ocumox Ophthalmic Solution 0.5% in bangla
Prof. Dr. Anisul Haque
Neurology (Brain, Stroke, Nerve, Headache, Migraine) Specialist
Neurology Doctor in Dhaka
Prof. Dr. Md. Mominul Haque
Skin, Allergy, Leprosy & Sexual Diseases Specialist
Sex Specialist Doctor in Rangpur